FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.
about
The role of CD95 and CD95 ligand in cancerA Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells.SUOX is negatively associated with multistep carcinogenesis and proliferation in oral squamous cell carcinoma.Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.
P2860
FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
FAS/FASL expression profile as ...... carcinoma of the oral cavity.
@ast
FAS/FASL expression profile as ...... carcinoma of the oral cavity.
@en
type
label
FAS/FASL expression profile as ...... carcinoma of the oral cavity.
@ast
FAS/FASL expression profile as ...... carcinoma of the oral cavity.
@en
prefLabel
FAS/FASL expression profile as ...... carcinoma of the oral cavity.
@ast
FAS/FASL expression profile as ...... carcinoma of the oral cavity.
@en
P2093
P2860
P50
P1433
P1476
FAS/FASL expression profile as ...... carcinoma of the oral cavity.
@en
P2093
Adriana Madeira Álvares da Silva-Conforti
Ana Maria da Cunha Mercante
Eloiza Helena Tajara
Marcelo dos Santos
Paulo Bentes de Carvalho-Neto
Viviane Priscila Pina dos Santos
P2860
P304
P356
10.1371/JOURNAL.PONE.0069024
P407
P577
2013-07-19T00:00:00Z